RAPT Therapeutics effects 1-for-8 reverse stock split; post-split shares ~16.5M

RAPT Therapeutics, Inc.

Stockholders approved reverse split at May 29, 2025 annual meeting.
Effective June 16, 2025, RAPT effected a 1-for-8 reverse stock split.
Post-split shares outstanding approx. 16.5 million (before eliminating fractional shares).
Certificate of Amendment filed with Delaware on June 13, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

RAPT Therapeutics, Inc.: Effected a 1-for-8 reverse stock split of common stock via Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2025-06-16).

Change: charter amendment
Effective: 2025-06-16

Exact text from the filing

Effective June 16, 2025 at 11:59 p.m. Eastern Time, the Company effected a 1-for-8 reverse stock split pursuant to a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on June 13, 2025.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0000950170-25-087359

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.